Prognosis in Patients with Non-Small Cell Lung Cancer and Satellite Tumors[*]

Abstract

Background: Aim of the study was to identify factors affecting survival in patients with lung cancer and satellite tumors (ST). Methods: Between 2001 and 2008, there were 102 patients with synchronous multiple lung cancers among the 1355 lung resections performed in lung cancer patients. Satellite tumors were found to be near the primary lung cancer (PLC) in 29 patients. Results: Complete resection was achieved in all patients, and the 5-year survival rate was 52 %. The independent “T” stages of the PLCs and STs did not affect survival (p = 0.98 and p = 0.54, respectively). A distance between the PLC and ST longer or shorter than 2, 3, or 4 cm also did not affect survival (p = 0.78, p = 0.57, and p = 0.62, respectively). The survival of patients treated with adjuvant therapy was significantly higher than that of patients who did not receive adjuvant therapy (p = 0.0043). Conclusions: Satisfactory survival was achieved after surgical therapy for non-small cell lung cancer associated with ST. While the PLC and ST characteristics and the distance between tumors did not affect survival rates, the introduction of adjuvant chemotherapy with/without radiotherapy positively affected survival.

lung cancer treatment (surgery - medical) - lung cancer - diagnosis (includes staging - imaging - fiducials) - chemotherapy - non‐small cell lung cancer - satellite tumors - surgery - prognosis

References

• 1 Shen K R, Meyers B F, Larner J M, Jones D R. American College of Chest Physicians . Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines. 2nd ed.  Chest. 2007;  132 290S-305S
• 2 Trousse D, D'Journo X B, Avaro J P et al. Multifocal T4 non-small cell lung cancer: a subset with improved prognosis.  Eur J Cardiothorac Surg. 2008;  33 99-103
• 3 Oliaro A, Filosso P L, Cavallo A et al. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.  Eur J Cardiothorac Surg. 2008;  34 438-443
• 4 Battafarano R J, Meyers B F, Guthrie T J, Cooper J D, Patterson G A. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival.  Ann Thorac Surg. 2002;  74 988-993
• 5 Deslauriers J, Brisson J, Cartier R et al. Carcinoma of the lung. Evaluation of satellite nodules as a factor influencing prognosis after resection.  J Thorac Cardiovasc Surg. 1989;  97 (4) 504-512
• 6 Mountain C F. A new international staging system for lung cancer.  Chest. 1986;  89 225-233
• 7 Detterbeck F C, Boffa D J, Tanoue L T. The new lung cancer staging system.  Chest. 2009;  136 260-271
• 8 Port J L, Korst R J, Lee P C, Kansler A L, Kerem Y, Altorki N K. Surgical resection for multifocal (T4) non-small cell lung cancer: is the T4 designation valid?.  Ann Thorac Surg. 2007;  83 397-400
• 9 Urschel J D, Urschel D M, Anderson T M, Anthowiak J G, Takita H. Prognostic implications of pulmonary satellite nodules: are the 1997 staging revisions appropriate?.  Lung Cancer. 1998;  21 83-87
• 10 Rao J, Sayeed R A, Tomaszek S, Fischer S, Keshavjee S, Darling G E. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.  Ann Thorac Surg. 2007;  84 934-938
• 11 Bryant A S, Pereira S J, Miller D L, Cerfolio R J. Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.  Ann Thorac Surg. 2006;  82 1808-1813
• 12 Mountain C F. Revisions in the international system for staging lung cancer.  Chest. 1997;  111 1710-1717
• 13 Detterbeck F C, Jones D R, Kernstine K H, Naunheim K S. American College of Physicians . Lung cancer. Special treatment issues.  Chest. 2003;  123 244-258
• 14 Pennathur A, Lindeman B, Ferson P et al. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.  Ann Thorac Surg. 2009;  87 893-899

1 This manuscript had been presented at the 13^th Annual Congress of the Turkish Thoracic Society, Lütfü Kırdar Congress Center in Istanbul on 5-9 May 2010.